Transient receptor potential channels as therapeutic targets - Test2 - elhamkhani - TriplyDB

Transient receptor potential channels as therapeutic targets

Transient receptor potential channels as therapeutic targets

http://www.wikidata.org/entity/Q28244558

about

TRIP database 2.0: a manually curated information hub for accessing TRP channel interaction network TRPV1: A Target for Rational Drug Design TRP Channels as Therapeutic Targets in Diabetes and Obesity TRPM3 in temperature sensing and beyond Deciphering Subtype-Selective Modulations in TRPA1 Biosensor Channels Signaling effectors underlying pathologic growth and remodeling of the heart TRP channels in skin: from physiological implications to clinical significances TRP channels and analgesia Modulation of thermoreceptor TRPM8 by cooling compounds Calcium influx pathways in breast cancer: opportunities for pharmacological intervention A Tarantula-Venom Peptide Antagonizes the TRPA1 Nociceptor Ion Channel by Binding to the S1–S4 Gating Domain Nociceptive TRP Channels: Sensory Detectors and Transducers in Multiple Pain Pathologies Heterologous expression and purification of an active human TRPV3 ion channel Inactivation of the constitutively active ghrelin receptor attenuates limbic seizure activity in rodents.A re-evaluation of 9-HODE activity at TRPV1 channels in comparison with anandamide: enantioselectivity and effects at other TRP channels and in sensory neurons Identification and analysis of cation channel homologues in human pathogenic fungi Inhibition of K+ transport through Na+, K+-ATPase by capsazepine: role of membrane span 10 of the α-subunit in the modulation of ion gating Spatial temperature gradients guide axonal outgrowth Terpenes and lipids of the endocannabinoid and transient-receptor-potential-channel biosignaling systems Neuronal TRPV1 activation regulates alveolar bone resorption by suppressing osteoclastogenesis via CGRP TNF-α/TNFR1 signaling is required for the development and function of primary nociceptors.Retinoids activate the irritant receptor TRPV1 and produce sensory hypersensitivity Transient receptor potential (TRP) channels: a clinical perspective TRP channels in the skin.Pharmacological profiling of the TRPV3 channel in recombinant and native assays.Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve.The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity.New insights into TRP channels: Interaction with pattern recognition receptors TRPA1 mediates bladder hyperalgesia in a mouse model of cystitis.Structural determinants of the transient receptor potential 1 (TRPV1) channel activation by phospholipid analogs Implication of transient receptor potential vanilloid type 1 in 14,15-epoxyeicosatrienoic acid-induced angiogenesis Are TRP channels involved in sperm development and function?Expression and distribution of TRPV2 in rat brain.Plant derived aporphinic alkaloid S-(+)-dicentrine induces antinociceptive effect in both acute and chronic inflammatory pain models: evidence for a role of TRPA1 channels Receptors, channels, and signalling in the urothelial sensory system in the bladder Cellular mechanism underlying formaldehyde-stimulated Cl- secretion in rat airway epithelium.Echinococcus granulosus genomics: a new dawn for improved diagnosis, treatment, and control of echinococcosis.Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1.The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction.Urinary metabolite profiling combined with computational analysis predicts interstitial cystitis-associated candidate biomarkers

P2860

Q21133944-5B202460-0365-40F2-8CC8-FD116B0301D5 Q26738621-9DF2A744-87CB-47D6-A7C3-CF5778A8729D Q26739958-BD5902CC-2CCD-48C3-80BF-3A0BC866FBF8 Q26745813-234D7478-FEED-4A29-BA1B-0EDF0610F804 Q26786467-D7C5538A-4C28-488C-B79E-8275A8DF377C Q26825154-357761CF-D0D4-476A-9392-459CBA825F32 Q26851557-91BB9F06-90E4-48DC-BBB9-6228F86D980D Q27021608-15FBA017-0CB3-4207-9B2B-4EB26F870B98 Q27021645-C5153B15-948B-431B-95CA-3E55DE92B6FD Q27025564-66962DA9-3569-4CCE-9FC4-D1C99F7397FB Q27681733-D90D8914-3DC3-49A2-AF9A-B1F77714D2E3 Q28073883-7A4E709E-D7FE-4362-988A-F7C178CD33BA Q28117574-98A852D3-1895-48B2-BDDC-40129E26B11C Q28268192-93523718-BDAC-48C4-88E3-7721DA8418A8 Q28272440-62348F6D-D8B4-409D-97BE-1D99B44B140B Q28481844-ED0F5681-2706-4D81-BB78-6EBB1EC8BD8A Q28538680-C9667683-6FCC-4E4D-85C2-6A2112D4C691 Q28828735-40E8320D-274C-4168-BC0A-830B435EDF26 Q28829964-34A141AE-87CF-47B8-A015-3518B2093477 Q28831006-AB8ED33D-671A-4055-8876-14DE6329AE9B Q30405316-3CEFD5FC-7C99-4A99-B3CA-B4F4AF3E3B80 Q30543743-4376525F-0B97-4094-B249-2C2A3C855C32 Q33562143-62CB3FFE-C483-4262-9ABB-90B8370CBEB0 Q33562177-CA662A8D-FCFA-4F0E-A54E-FC8B954686EB Q33562195-23C7D351-E748-4109-9E2C-EF282A150CF5 Q33617012-961862C5-B151-41E6-B657-7E9EF568CB36 Q33672384-2B65FF60-E4DB-40F0-8283-00A48FFE4C89 Q33721868-C3962683-FB58-4823-BDC8-88ED33CC3624 Q33758307-CEC42A28-1399-4C53-BAF8-BC87955F3067 Q34107164-7F78C9D5-718A-4996-B9CC-11A2A79D5110 Q34157821-A3B73321-477A-4331-BADF-86CB0F5C9BF8 Q34266973-5C7654AC-91E6-431B-A292-28D6F07E1B6A Q34323216-BC55566A-B2C3-4516-9718-376D9F8E667C Q34357951-910EBAA5-A916-4413-985C-96ED0C9F6C01 Q34516186-13FB8F4B-1B55-403B-8890-3DC37C30BCE9 Q34571202-959BED72-4270-469B-AE17-62780175FC66 Q34709601-6BA56D96-32BC-4C2A-82C2-2B50897DB9FB Q34720114-DE88A495-2B33-4719-B921-6E4A5098E7FC Q34820753-960D465F-4E40-4226-B82C-4E9C726F7CD9 Q34855915-60946517-43D0-429B-BEB9-41B6FFD96971

P2860

Transient receptor potential channels as therapeutic targets

http://www.wikidata.org/entity/Q28244558

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Transient receptor potential channels as therapeutic targets

@ast

Transient receptor potential channels as therapeutic targets

@en

Transient receptor potential channels as therapeutic targets

@nl

type

label

Transient receptor potential channels as therapeutic targets

@ast

Transient receptor potential channels as therapeutic targets

@en

Transient receptor potential channels as therapeutic targets

@nl

prefLabel

Transient receptor potential channels as therapeutic targets

@ast

Transient receptor potential channels as therapeutic targets

@en

Transient receptor potential channels as therapeutic targets

@nl

P1433

Q28244558-BA2D82BB-FEFA-461D-AA0F-6E4ECA1EDB9C

P1476

Q28244558-B5A18C52-EA17-4224-8B24-DF7AE2416C25

P2093

Q28244558-245A1A44-EE11-45A2-8997-2E5323E13E7E

Q28244558-5406E9C6-B5B1-4CF0-8A2A-9B42B5244460

Q28244558-C07465D1-7302-4761-AE15-EB07E70CB177

Q28244558-E2550D41-3628-41EF-B6F6-A77E4CFA0ED4

P2860

Q28244558-00CF5A54-BF80-4C68-9CD4-375583992610

Q28244558-00DC0E03-F86D-46A1-A01D-A9C99D515A53

Q28244558-0372E26D-6BA3-4DF3-903C-720BD2AE7487

Q28244558-03BD6CA0-61CC-4E8B-B07B-0DF48A4DF605

Q28244558-04E04315-80D7-469C-BFA4-2397659A7163

Q28244558-05EF64CD-4C58-4581-9C46-C5B24C6FFF24

Q28244558-05F46EE3-88C0-43F8-9EDB-855E869098B2

Q28244558-093813D1-CE61-42FD-A0D3-395DF839CCE4

Q28244558-09E4DD09-99F0-41F1-A0EC-F6B837394167

Q28244558-0ADB6D32-E508-423A-BA41-4B63B6A41A77

P2888

Q28244558-85E4C268-B1A9-4F9D-83EF-23527372AECA

P304

Q28244558-C751D0D4-F4D3-4AB6-8A38-D2154533EC0F

P31

Q28244558-BEED4240-E60C-4822-A393-F234770E6FB4

P3181

Q28244558-77D33E25-7CCD-4B75-B5FF-2F622D83963B

P356

Q28244558-19E3665C-6157-433E-AB8C-2EFA95B63CFA

P407

Q28244558-3FC8F722-1761-4D7E-92FB-E91F4C2F2E83

P433

Q28244558-2CA70DF5-9DC1-4F5E-9E32-6D30313D7A9A

P478

Q28244558-E74028A7-CE58-4CF3-A3BB-5C258FDE1DB0

P577

Q28244558-8C8E216C-6D16-4425-A9D8-C694D7956623

P5875

Q28244558-AA80D1B7-1E3E-4677-A8A3-76D8521E12FD

P698

Q28244558-1C203714-477F-4697-8907-3D7349EE5CD3

P3181

P356

P1433

Nature Reviews Drug Discovery

P1476

Transient receptor potential channels as therapeutic targets

@en

P2093

Arpad Szallasi

http://www.w3.org/2001/XMLSchema#string

Magdalene M Moran

http://www.w3.org/2001/XMLSchema#string

Michael Allen McAlexander

http://www.w3.org/2001/XMLSchema#string

Tamás Bíró

http://www.w3.org/2001/XMLSchema#string

P2860

TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation

Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I

Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans

Mutations in TRPM1 are a common cause of complete congenital stationary night blindness

A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome

The capsaicin receptor: a heat-activated ion channel in the pain pathway

Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations

Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C

Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis

International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family

P2888

P304

601-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

164973

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRD3456

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51535853

http://www.w3.org/2001/XMLSchema#string

P698

21804597

http://www.w3.org/2001/XMLSchema#string